Atypical presentation of histoplasmosis as secondary immune thrombocytopenia: case report
The development of immune thrombocytopenia has been characterized as an acquired disorder, the most frequent presentation of which is isolated thrombocytopenia. When the cause is determined, it is established as secondary and a favorable response can b
Azar MM, Loyd JL, Relich RF, Wheat LJ, Hage CA. Current concepts in the epidemiology, diagnosis, and management of histoplasmosis syndromes. Semin Respir Crit Care Med [Internet]. 2020;41(1):13–30. Disponible en: http://dx.doi.org/10.1055/s-0039-1698429
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv [Internet]. 2019;3(23):3829–66. Disponible en: http://dx.doi.org/10.1182/bloodadvances.2019000966
Araúz AB, Papineni P. Histoplasmosis. Infect Dis Clin North Am [Internet]. 2021;35(2):471–91. Disponible en: http://dx.doi.org/10.1016/j.idc.2021.03.011
Sandal R, Mishra K, Jandial A, Sahu KK, Siddiqui AD. Update on diagnosis and treatment of immune thrombocytopenia. Expert Rev Clin Pharmacol [Internet]. 2021;14(5):553–68. Disponible en: http://dx.doi.org/10.1080/17512433.2021.1903315
Copyright (c) 2023 Luis Escobedo
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
